Clinical Trials Directory

Trials / Completed

CompletedNCT03296956

A Dietary Supplement for Mood Symptoms in Early Postpartum: A Double Blind Randomized Placebo Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Centre for Addiction and Mental Health · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether a dietary supplement (DS) is effective in protecting against sad mood in postpartum as compared to placebo.

Detailed description

This double blind placebo controlled randomized trial will evaluate the effect of administration of a dietary supplement (DS) on the intensity of postpartum blues. It is expected that the administration will result in less sadness in day-5 postpartum women after negative mood induction in those receiving the dietary supplement compared to placebo.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMotherwellThe interventions involves a dietary supplement called Motherwell, at current stage, to reduce the intensity of sadness in day-5 postpartum women.
OTHERPlaceboMatching placebo for appearance, taste

Timeline

Start date
2018-12-01
Primary completion
2022-12-25
Completion
2023-06-20
First posted
2017-09-29
Last updated
2023-10-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03296956. Inclusion in this directory is not an endorsement.